SCHEMBL2697033

SCHEMBL2697033

C=C(C)C1/C=C/C(C)CC/C=C(\C)CC1

nearest known ligand 0.45

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.45
MEN1 O00255 1/20 0.33
CNR2 P34972 1/20 0.33
KMT2A Q03164 1/20 0.33
PPARA Q07869 1/20 0.33
CNR1 P21554 1/20 0.31
TAS2R46 P59540 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31545657 0.74
SCHEMBL30105717 0.74
SCHEMBL6879361 0.74
SCHEMBL5502133 0.74
SCHEMBL17867128 0.71 LMNA (0.45) LMNAMEN1KMT2ATAS2R46
SCHEMBL11682073 0.69
SCHEMBL797521 0.66 LMNA (0.37) LMNA
SCHEMBL2941361 0.66 LMNA (0.46) LMNAMEN1CNR2KMT2ACNR1
SCHEMBL23360385 0.65 LMNA (0.86) LMNAMEN1CNR2KMT2APPARA
Cembrene_A SCHEMBL2041140 0.65 LMNA (0.86) LMNAMEN1CNR2KMT2APPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230087321-A1 ODORLESS CANNABIS PLANT BetterSeeds Ltd. (IL) 2023-03-23 US claimed
US-20230076088-A1 GAS PHASE METHODS TO EXTRACT NATURAL PRODUCTS Natural Extraction Systems, LLC (US) 2023-03-09 US claimed
EP-4114169-A1 ODORLESS CANNABIS PLANT Betterseeds Ltd. (IL) 2023-01-11 EP claimed
WO-2021176450-A1 ODORLESS CANNABIS PLANT CANBREED LTD. (IL) 2021-09-10 WO claimed
WO-2021159088-A1 GAS PHASE METHODS TO EXTRACT NATURAL PRODUCTS Natural Extraction Systems, LLC (US) 2021-08-12 WO claimed
US-12606535-B2 Gas phase methods to extract natural products Natural Extraction Systems, LLC (US) 2026-04-21 US disclosed
EP-4688735-A1 POLYTHIOL COMPOSITIONS AND METHOD FOR PREPARING SAME FROM TERPENES OR TERPENE DERIVATIVES ARKEMA France (FR) 2026-02-11 EP disclosed
US-12465628-B2 Cannabinoid carrier compositions having enhance pharmacokinetic properties and methods of use thereof DESERT HARVEST, INC. (US) 2025-11-11 US disclosed
US-12397061-B2 Systems, methods, and compositions for the generation of water-soluble cannabinoids utilizing fatty-acid binding proteins and fatty-acid binding-like proteins as cannabinoid-carriers TRAIT BIOSCIENCES, INC. (US) 2025-08-26 US disclosed
US-20250263630-A1 ELECTRONIC INHALATION DEVICE SCIENTIFIC HOLDINGS, LLC (US) 2025-08-21 US disclosed
US-20250250504-A1 WRAPPED INHALABLE SUBSTANCE SCIENTIFIC HOLDINGS, LLC (US) 2025-08-07 US disclosed
US-12378499-B1 Wrapped inhalable substance SCIENTIFIC HOLDINGS, LLC (US) 2025-08-05 US disclosed
US-9404130-B2 Microbial engineering for the production of chemical and pharmaceutical products from the isoprenoid pathway MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2016-08-02 US disclosed
US-20160151328-A1 Terpene-Based Compositions, Processes Methodologies The Werc Shop, LLC (US) 2016-06-02 US disclosed
US-20150152446-A1 MICROBIAL ENGINEERING FOR THE PRODUCTION OF CHEMICAL AND PHARMACEUTICAL PRODUCTS FROM THE ISOPRENOID PATHWAY NATIONAL UNIVERSITY OF SINGAPORE (SG) 2015-06-04 US disclosed
WO-2015042232-A1 IMPROVED TERPENE-BASED COMPOSITIONS, PROCESSES, METHODOLOGIES FOR CREATION AND PRODUCTS THEREBY The Werc Shop, LLC (US) 2015-03-26 WO disclosed
US-20150080265-A1 TERPENE-BASED COMPOSITIONS, PROCESSES, METHODOLOGIES FOR CREATION AND PRODUCTS THEREBY SCIENTIFIC HOLDINGS, LLC 2015-03-19 US disclosed
US-8927241-B2 Microbial engineering for the production of chemical and pharmaceutical products from the isoprenoid pathway MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2015-01-06 US disclosed
US-20130302861-A1 EXPRESSION CONSTRUCTS AND USES THEREOF IN THE PRODUCTION OF TERPENOIDS IN YEAST YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2013-11-14 US disclosed
US-20120107893-A1 MICROBIAL ENGINEERING FOR THE PRODUCTION OF CHEMICAL AND PHARMACEUTICAL PRODUCTS FROM THE ISOPRENOID PATHWAY MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2012-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12606535-B2 Gas phase methods to extract natural products CFD, MAX, NPM1 LMNA 1685/4885MEN1 1525/4885CNR2 1275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.